Drug Use Investigation of Ventavis for Pulmonary Arterial Hypertension (PAH)
Phase of Trial: Phase IV
Latest Information Update: 18 May 2017
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions
- Acronyms JPMS-Ventavis
- Sponsors Bayer
- 07 Jun 2017 Biomarkers information updated
- 14 Sep 2016 Status changed from not yet recruiting to recruiting.
- 18 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Aug 2016.